At a glance
ClinicalIndex Comparison RecordN/ACompleted· 180 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessment of the Structure and Function of Heart and Selected Cardiovascular Risk Factors in Patients With Acute Intermittent Porphyria
National Institute of Cardiology, Warsaw, Poland·observational·Posted May 31, 2023·Updated Apr 2, 2024
In Brief
An observational study for Porphyrias, Hepatic. Completed, enrolled 180 participants across 2 sites.
Detailed Summary
This study aims to assess the changes in the cardiovascular system in patients with acute intermittent porphyria (AIP).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPorphyrias, Hepatic
CountriesPoland
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartApr 2019
First PostedMay 2023
Primary CompletionFeb 2024
TodayJul 2026
First PostedMay 31, 2023
Enrollment StartApr 5, 2019
Primary CompletionFeb 28, 2024
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 3.1 years ago